Inhibition of mast cell histamine release by specific phosphodiesterase inhibitors

Inflammation Research

Volumn 54, Issue SUPPL. 1, 2005, Pages

  Lau, H Y A ^a   Kam, M F A ^a  

^a Prince of Wales Hospital   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; HISTAMINE; IMMUNOGLOBULIN E ANTIBODY; ROLIPRAM; SIGUAZODAN;

ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HISTAMINE RELEASE; IMMUNOREACTIVITY; INFLAMMATION; INHIBITION KINETICS; MEDIATOR RELEASE; NONHUMAN; PERITONEUM MAST CELL; RAT;

4-(3-BUTOXY-4-METHOXYBENZYL)-2-IMIDAZOLIDINONE; ANIMALS; GUANIDINES; HISTAMINE; MAST CELLS; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; PROTEIN ISOFORMS; PYRIDAZINES; RATS; RATS, SPRAGUE-DAWLEY; ROLIPRAM;

EID: 21144448258     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-004-0401-2     Document Type: Conference Paper

References (4)

1. Schwartz LB. Mast cells: function and contents. Curr Opin Immunol 1994; 6: 91-7.
2. Alfonso A, Estevez M, Louzao M, Vieytes MR, Botana LM. Determination of phosphodiesterase activity in rat mast cells using the fluorescent cAMP analogue anthraniloyl cAMP. Cell Signal. 1995; 7: 513-8.
3. Weston MC, Anderson N, Peachell PT. Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function. Brit J Pharmacol. 1997; 121: 287-95.
4. Chan CL, Jones RLJ, Lau HYA. Characterization of prostanoid receptors mediating inhibition of histamine release from anti-IgE-activated rat peritoneal mast cells. Brit J Pharmacol 2000; 129: 589-97.